CLINICAL_TRIALS
trial_result
· 2017-07-11
Clinical Trial Update: A Study Of The Effects Of CB2 Compound Of GW842166 In Patients With Osteoarthritis [Phase 2]
Summary
Phase 2 study evaluating a CB2 receptor agonist GW842166 in osteoarthritis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Osteoarthritis | Phase 2 | Status: COMPLETED